Tarsus Pharmaceuticals (TARS) Inventory Average (2023 - 2026)

Tarsus Pharmaceuticals' Inventory Average history runs 4 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 67.96% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 67.96% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, up 22.09% from the prior year.
• Inventory Average climbed to $4.5 million in Q1 2026 per TARS's latest filing, from $4.1 million in the prior quarter.
• Across five years, Inventory Average topped out at $4.5 million in Q1 2026 and bottomed at $1.6 million in Q4 2023.
• The 4-year median for Inventory Average is $3.2 million (2024), against an average of $3.2 million.
• Across the five-year window, Inventory Average jumped 75.08% in 2024 and dropped 25.45% in 2025, its largest moves.
• Year by year, Inventory Average stood at $1.6 million in 2023, then soared by 75.08% to $2.7 million in 2024, then surged by 50.16% to $4.1 million in 2025, then grew by 8.97% to $4.5 million in 2026.
• Per Business Quant, the three latest TARS Inventory Average figures stand at $4.5 million (Q1 2026), $4.1 million (Q4 2025), and $3.9 million (Q3 2025).